Articles

12 articles
Tag: pharmaceutical ✕
KRAS Cancer Drugs: Once 'Undruggable' Mutation Now Targeted by Multiple Promising Treatments in Clinical Trials Science
2026-04-08T10:34:27.297Z · Src: 2026-04-08T00:00:00.000Z
krascancerdrug development
The Computational Biology Platform War: How AI Is Democratizing Drug Discovery and Molecular Design Science
2026-04-05T00:56:39.536Z · Src: 2026-04-04T00:00:00.000Z
computational biologalphafolddrug discovery
The Graph Neural Network Breakthrough: Why GNNs Are Transforming Drug Discovery and Materials Science Tech
2026-04-04T21:54:54.237Z · Src: 2026-04-04T00:00:00.000Z
graph neural networkgnndrug discovery
The Biotech AI Convergence: How Foundation Models Are Accelerating Drug Discovery and Genomic Medicine Science
2026-04-04T17:55:59.286Z · Src: 2026-04-04T00:00:00.000Z
biotechaidrug discovery
The Cold Chain Revolution: How AI and IoT Are Transforming Global Food and Pharmaceutical Logistics Tech
2026-04-04T17:21:51.974Z · Src: 2026-04-04T00:00:00.000Z
cold chainiotai
How Aspirin Went from Willow Bark to a Drug That Saves Millions of Lives Annually Science
2026-04-02T08:53:50.816Z · Src: 2026-04-02T00:00:00.000Z
aspirinpharmaceuticalbayer
How mRNA Technology Beyond COVID Is Transforming Medicine Science
2026-04-01T12:56:00.831Z · Src: 2026-04-01T00:00:00.000Z
mrnamodernabiontech
The Insulin Affordability Crisis: Why a 100-Year-Old Drug Still Costs Hundreds Science
2026-04-01T12:47:48.078Z · Src: 2026-04-01T00:00:00.000Z
insulinhealthcarepharmaceutical
The Antibiotic Crisis: 10 Million Deaths Annually by 2050 Without New Drugs Science
2026-04-01T12:42:54.829Z · Src: 2026-04-01T00:00:00.000Z
antibiotic resistancsuperbugsamr
Samsung Biologics Acquires GSK US Factory for $280M to Expand Global Manufacturing Tech
2026-04-01T06:54:15.702Z · Src: 2026-04-01T13:00:00.000Z
samsunggskbiologics
Biogen to Acquire Apellis Pharmaceuticals for $5.6 Billion in Rare Disease Expansion Business
2026-03-31T12:54:14.765Z · Src: 2026-03-31T12:00:00.000Z
biogenapellism a
Biogen to Acquire Apellis for $5.6B, Expanding into Immunology and Rare Disease Business
2026-03-31T12:52:55.829Z · Src: 2026-03-31T12:44:00.000Z
biogenapellism a